Trials / Completed
CompletedNCT02069821
Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects
An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of Exforge® (Amlodipine Besylate/Valsartan) and Lipitor® (Atorvastatin Ca) in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the pharmacokinetic interactions between amlodipine besylate/valsartan and atorvastatin single or co-administered in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | combination administration | combination administration : amlodipine/valsartan 10/160mg and atorvastatin 40mg, qd, 10days(oral) |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-03-01
- Completion
- 2014-07-01
- First posted
- 2014-02-24
- Last updated
- 2017-09-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02069821. Inclusion in this directory is not an endorsement.